[1] 黄志强, HUANG Zhi-qiang. 肝门部胆管癌外科治疗--效果有待提高 [J]. 临床外科杂志 2006.doi:10.3969/j.issn.1005-6483.2006.02.001
[2] 金安琴, 黄晓俊, 高祝英, 樊红, 王祥, 冯彦虎, JIN An-qin, HUANG Xiao-jun, GAO Zhu-ying, FAN Hong, WANG Xiang, FENG Yan-hu. 胆管癌患者血清和胆汁癌胚抗原与糖类抗原242的测定及其临床意义 [J]. 兰州大学学报（医学版） 2009.doi:10.3969/j.issn.1000-2812.2009.02.019
[3] 邹声泉, JU Sheng-quan. 胆汁蛋白质组研究筛选胆道肿瘤早期诊断标志物的意义 [J]. 外科理论与实践 2009.
[4] Andreas Weber, Roland H Schmid, Christian Prinz. Diagnostic approaches for cholangiocarcinoma [J]. 世界胃肠病学杂志（英文版） 2008.
[5] 刘振峰, 刘建英, 郑洪, 邱丹, LIU Zhen-feng, LIU Jian-ying, ZHENG Hong, QIU Dan. MCM5和Ki-67在非小细胞肺癌组织中的表达及意义 [J]. 山东医药 2008.doi:10.3969/j.issn.1002-266X.2008.05.003
[6] 郑启昌, 陈海波, 左克强, 张勇. β-连环蛋白在肝门部胆管癌中的表达及其与c-myc表达的关系 [J]. 中国普外基础与临床杂志 2005.doi:10.3969/j.issn.1007-9424.2005.01.021
[7] 黄国飞, 王济明, 罗诗樵, 吕济相, HUANG Guo-fei, WANG Ji-ming, LUO Shi-qiao, LV Ji-xiang. 人胆管癌与正常人胆汁蛋白质组学研究 [J]. 中国癌症杂志 2009.doi:10.3969/j.issn.1007-3639.2009.02.008
[8] 刘厚宝, 王炳生, 陈惠黎, 童赛雄, 赵家宏. 胆管癌胆管胆汁中糖蛋白糖链结构变化及其酶学机制 [J]. 中国临床医学 2006.doi:10.3969/j.issn.1008-6358.2006.06.032
[9] 董辉, 丛文玲, 朱忠政, 王斌, 冼志红, 俞花, DONG Hui, CONG Wen-ling, ZHU Zhong-zheng, WANG Bin, XIAN Zhi-hong, YU Hua. 肝细胞癌与肝内胆管癌的免疫组化诊断 [J]. 中华肿瘤杂志 2008.doi:10.3321/j.issn:0253-3766.2008.09.015
[10] 方萃福, 李松岗, 全志伟, FANG Cui-fu, LI Song-gang, QUAN Zhi-wei. 胆道恶性肿瘤的分子生物学诊断进展 [J]. 国际外科学杂志 2010.doi:10.3760/cma.j.issn.1673-4203.2010.07.018
[11] Selaru FM, Olaru AV, Kan T, David S, Cheng Y, Mori Y, Yang J, Paun B, Jin Z, Agarwal R, Hamilton JP, Abraham J, Georgiades C, Alvarez H, Vivekanandan P, Yu W, Maitra A, Torbenson M, Thuluvath PJ, Gores GJ, LaRusso NF, Hruban R, Meltzer SJ. MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. [J]. Hepatology: Official Journal of the American Association for the Study of Liver Diseases 2009, 5(5).
[12] Oshiro H, Matsuo K, Mawatari H, Inayama Y, Yamanaka S, Nagahama K, Endo I, Shimada H, Nakajima A, Kubota K. [J]. Pathology International 2008.
[13] FARIN A, DUMONCEAU J M, FROSSARD J L. protemicanalysis of human bile from malignant biliary stenosis induced by pancereatic cancera [J]. Journal of Proteome Research 2009, 8(01).
[14] Zhang Y, Zhang J, Lin Y, Lan Y, Lin C, Xuan JW, Shen MM, McKeehan WL, Greenberg NM, Wang F. [J]. Development 2008.
[15] IMOTO Y, MUGURUMA N, KIMURA T. Relationship between mucin expression and preoperative bile juice cytology in bilary tract carcinoma [J]. Journal of Medical Investigation 2007, 54(1/2).
[16] P1ESSEN G, JONCKHEERE N, VINCENT A. Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodexycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor l alpha [J]. Biochemical Journal 2007, 402(01).
[17] MICIC I D, MITKOVIC M B, MLADENOVIC D S. Treament of the humeral shaft aseptic nonunion using plate or unilateral external fixator [J]. Journal of Trauma-Injury Infection and Critical Care 2008, 64(05).
[18] Singh AP, Moniaux N, Chauhan SC, Meza JL, Batra SK. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. [J]. Cancer research 2004, 2(2).
[19] Matull WR, Andreola F, Loh A, Adiguzel Z, Deheragoda M, Qureshi U, Batra SK, Swallow DM, Pereira SP. MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. [J]. The British journal of cancer 2008, 10(10).
[20] TAMADA S, SHIBAHARA, HIGASHI M. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma [J]. Clinical Cancer Research 2006, 12(14 Pt 1).
[21] Yeh CN, Pang ST, Wu RC, Chen TW, Jan YY, Chen MF. [J]. Oncology reports 2009.
[22] Giaginis C, Georgiadou M, Dimakopoulou K, Tsourouflis G, Gatzidou E, Kouraklis G, Theocharis S. Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity. [J]. Digestive Diseases and Sciences 2009, 2(2).
[23] Ayaru L, Stoeber K, Webster GJ, Hatfield AR, Wollenschlaeger A, Okoturo O, Rashid M, Williams G, Pereira SP. [J]. The British journal of cancer 2008.
[24] Chen CY, Tsai WL, Wu HC, Syu MJ, Wu CC, Shiesh SC. [J]. Clinica chimica acta: International journal of clinical chemistry and applied molecular biology 2008.
[25] Liu J, Xing Y, Hinds TR, Zheng J, Xu WQ. [J]. Journal of Molecular Biology 2006.
[26] XU Yin, LIU Yaojuan, YU Qin. Angiopoietin-3 inhibits pulmonary metastasis by inhibiting tumor angiogenesis [J]. Cancer Research 2004, 64(17).
[27] KOOPMANN J, THULUVATH P J, ZAHURAKM M L. Mac-2-binding proein is a diagnostic marker for biliary tract carcinoma [J]. Cancer 2004, 101(07).
[28] ALVARO D, MACARRI G, MANCINO M G. Serum and biliary insulin-like growth factor and vascular endothelial growth factor in determining the cause of obstructive cholestasis [J]. Annals of Internal Medicine 2007, 147(07).
[29] Rau S, Autschbach F, Riedel HD, Konig J, Kulaksiz H, Stiehl A, Riemann JF, Rost D. Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas. [J]. European journal of clinical investigation 2008, 2(2). |
